Literature DB >> 1476545

Histiocytic cytophagic panniculitis: molecular evidence for a clonal T-cell disorder.

P Hytiroglou1, R G Phelps, D J Wattenberg, J A Strauchen.   

Abstract

Histiocytic cytophagic panniculitis is a systemic disease of unknown etiopathogenesis that invariably involves the subcutaneous fat and is histologically characterized by phagocytosis of blood elements by histiocytes that appear to be benign. Immunophenotypic and genotypic studies of biopsy specimens of the lesions of a 58-year-old woman showed that the lymphocytic infiltrates accompanying the histiocytes in the subcutis were composed of clonal T-cells with rearrangement of the surface receptor gene. Our findings suggest that the primary abnormality in histiocytic cytophagic panniculitis may be a clonal T-cell proliferation.

Entities:  

Mesh:

Year:  1992        PMID: 1476545     DOI: 10.1016/0190-9622(92)70194-k

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  A case of cytophagic histiocytic panniculitis: successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A.

Authors:  S Nakane; Y Kawabe; K Eguchi; A Kita; A Mizokami; H Yamasaki; S Nagataki
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

Review 2.  Intravenous immunoglobulin in lupus panniculitis.

Authors:  João Espírito Santo; M F Gomes; M J Gomes; L Peixoto; S C Pereira; A Acabado; J Freitas; G Vinhas de Sousa
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.

Authors:  Anna Wozniacka; Małgorzata Salamon; Aleksandra Lesiak; Daniel Paul McCauliffe; Anna Sysa-Jedrzejowska
Journal:  Clin Rheumatol       Date:  2006-04-28       Impact factor: 3.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.